CAFL
|
Abdominal Inflammation
|
1.2
125
146
1550
1600
1800
1865
20
2170
2489
2720
380
428
440
444
450
465
660
72
727
776
787
802
832
880
95
|
CAFL
|
Abdominal Pain
|
10000
124
160
26
3
3000
3040
440
522
95
|
ETDF
|
Addictions Alcohol General
|
1500
184000
230
2300
283000
290
303400
3300
440
83350
|
CAFL
|
Adnexitis
|
3343
3833
440
441
522
5312
572
|
VEGA
|
Adnexitis
|
3343
3833
440
441
522
5312
572
|
CAFL
|
Adrenal Gland Stimulant 2
|
10
125
1500
1600
1800
1865
20
2127
2170
2720
3000
428
440
444
450
522
600
625
650
660
666
685
690
700
72
727
760
787
832
880
95
|
XTRA
|
Adrenal Gland Stimulant 3
|
10
125
1500
1550
1600
1800
1865
20
2008
2127
2170
2720
3000
428
440
444
450
522
600
625
650
660
666
685
690
700
72
727
760
776
787
832
880
95
|
ETDF
|
Adverse Drug Reaction
|
140
1860
200
330
420
440
520
550
760
780
|
XTRA
|
Alignment of Individual
|
10000
125
20
225
427
440
5000
60
660
727
787
800
880
95
|
CAFL
|
Appendicitis
|
10
125
146
1550
190
20
380
440
444
450
522
650
72
727
787
802
880
95
|
CAFL
|
Cancer
|
1050
1550
20
2180
3672
440
55.56
6.8
663
778
|
XTRA
|
Cancer 4 W1
|
339
440
448
463
468
574
590
666
668
676
697
732
737
770
786
|
CAFL
|
Cancer Additional Frequencies 1
|
1050
1550
20
2180
3672
440
55.56
618
663
778
|
XTRA
|
Cancer Basic 2
|
10000
10022
10025
10026
10027
1050
11162
11503.9
1352
19611.45
2008
2098
2127.5
2180
2182
2184
2720
3000
3672
440
55.56
6.79
644
660
663
690
727.5
778
901
95
|
XTRA
|
Cancer Basic 7
|
1050
11162.11
11503.9
1550
2180
3672
440
55.56
6.79
663
778
|
XTRA
|
Cancer Cells
|
0.16-1.35
440
6.8
|
XTRA
|
Cancer Experimental Additional
|
1050
1550
2180
3672
440
55.56
6.79
66.5
663
778
|
CAFL
|
Cancer Experimental Additional Frequencies
|
1050
1550
2180
3672
440
55.56
6.8
663
778
|
XTRA
|
Cancer Leukemia 2
|
10000
14
15
1850
2008
2030
2127
422
428
440
450
465
590
6.79
666
690
727
787
822
880
|
XTRA
|
Chemical Sensitivity Reduce 1
|
440
|